Searchable abstracts of presentations at key conferences in endocrinology

ea0038p299 | Pituitary | SFEBES2015

A role for 11C-methionine PET/CT–MRI in the management of de novo and residual acromegaly

Koulouri Olympia , Hoole Andrew , Steuwe Andrea , Gillett Daniel , Powlson Andrew , Akker Scott , Aylwin Simon , Brooke Antonia , Buch Harit , Drake Will , Levy Miles , Siddiqi Ayesha , Simpson Helen , Chatterjee Krishna , Burnet Neil , Antoun Nagui , Cheow Heok , Mannion Richard , Pickard John , Gurnell Mark

Background: Although MRI remains the investigation of choice for pituitary imaging, it does not provide information about the ‘functionality’ of lesions (e.g. residual adenoma vs post-surgical scar tissue), and cannot reliably identify all microadenomas. These limitations are of particular relevance in acromegaly where clinical and biochemical evidence of disease activity mandates (further) treatment.Methods: We hypothesised that i) imaging wit...

ea0031p164 | Neoplasia, cancer and late effects | SFEBES2013

Diagnosis, localisation and management of insulinoma; a single-centre experience

Powlson Andrew S , Challis Benjamin , Curran Suzanne , Jah Asif , Praseedom Raj , Huguet Emmanuel , Jamieson Neville , Metz Andrew , Carroll Nicholas , Shaw Ashley , Halsall David , Gurnell Mark , Krishna Chatterjee V , Simpson Helen L

Nineteen cases of insulinoma were treated in this centre between 2003 and 2012 (12 female, 7 male, 5 associated with MEN-1). Of the cohort, 14 had their primary investigation and management here. All presented with symptoms consistent with hypoglycaemia and had a supervised fast demonstrating serum glucose <2.2 mmol/l with inappropriately normal/elevated insulin.11 of 14 patients proceeded to surgery. Two elderly patients declined further investigati...

ea0028p251 | Pituitary | SFEBES2012

The characterisation of growth hormone-related cardiac disease with magnetic resonance imaging

Thomas Julia , Dattani Abhishek , Burchell Thomas , Zemrak Filip , Khoo Bernard , Chew Shern , Kaplan Felicity , Drake William , Aylwin Simon , Gurnell Mark , Akker Scott , Petersen Steffen , Davies Ceri , Grossman Ashley , Korbonits Marta

Acromegaly causes a distinct cardiomyopathy. Growth hormone deficiency (GHD) limits cardiac response to exercise and increases cardiac mortality. Cardiac magnetic resonance imaging (CMR) is considered the gold standard for assessment of cardiac mass and provides data on function, fibrosis, valves and ischaemia. Twenty-three patients with abnormal GH levels (acromegaly, n=13; adult-onset GHD, n=10) and 23 matched controls underwent CMR. Patients had repeat CMR at ...

ea0019p241 | Pituitary | SFEBES2009

The acromegalic cardiovascular and respiratory outcomes with primary analogue therapy (A.C.R.O.P.A.T.) trial

Webb A , Gayton E , Annamalai A , Pilsworth S , Wallace S , Khan S , O'Toole S , Ariyaratnam S , Maki-Petaja K , Scoffings D , Antoun N , Wilkinson I , Dutka D , Shneerson J , Simpson H , Gurnell M

Seventeen newly-diagnosed acromegalic patients (8 female, 9 male: mean age 55 year, range 26–73 year) were recruited to the A.C.R.O.P.A.T. trial. Patients were assessed prior to, and following, 6 months of treatment with Somatuline Autogel® (SA).Growth hormone (GH) & insulin-like growth factor 1 (IGF1): Following treatment, GH and IGF1 levels fell significantly in all but one subject: median GH change −17.23 mU/l (interquar...

ea0013p247 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

Sleep disorders and response to treatment in the ‘Acromegalic cardiovascular and respiratory outcomes with primary analogue therapy (ACROPAT)’ trial

Webb Alison , Pilsworth Sam , O’Toole Sam , Strey Chris , Ariyaratnam Shaumya , George Emad , Majeed Joohi , Melvin Alison , Morrish Nick , Roland Jonathan , Smith Ian , Wood Diana , Chatterjee Krishna , Simpson Helen , Shneerson John , Gurnell Mark

Respiratory disorders are a major cause of illness and impaired physical function in patients with acromegaly, contributing to 25% of all recorded deaths, with respiratory mortality 3-fold higher than in normal subjects. Sleep apnoea (SA), the phenomenon of recurrent cessation or decrease of airflow to the lungs during sleep, is the commonest reported respiratory complication. Both obstructive (OSA) and central (CSA) sleep apnoeas are known to occur, although the overall preva...

ea0012oc13 | Placenta, bone and genetics | SFE2006

A kindred with Carney Complex due to a novel PRKAR1A gene mutation (c1067_1070 del AACG ins GCCCA)

Strey C , Randall J , Conroy S , Horvath A , Weissberg P , Berman L , Dixon A , Hoffman G , Cooper J , Firth H , Wood D , Simpson H , Chatterjee K , Stratakis C , Melvin A , Gurnell M

RP (a 60 yr-old male) was found to have multiple atrial myxomata, whilst being investigated for recurrent attacks of amaurosis fugax affecting his left eye. During the preceding twenty years he had undergone repeated resections of cutaneous tumours, which were reported as neurofibromata. A clinical diagnosis of Carney Complex (CNC) was made based on the presence of multiple cutaneous nodules and atrial myxomata. RP displayed mild acromegalic features, but no pigmentation abnor...

ea0007p45 | Diabetes, metabolism and cardiovascular | BES2004

Transcriptional interference by novel human PPARgamma mutants associated with lipodystrophic insulin resistance

Agostini M , Schoenmakers E , Smith A , Szatmari I , Rajanayagam O , Savage D , Mitchell C , Clarke M , Zalin A , Trembath R , Kumar S , Schwabe J , Nagy L , O'Rahilly S , Gurnell M , Chatterjee V

The nuclear receptor PPARgamma is important for biological processes including adipogenesis and glucose homeostasis. In subjects with severe insulin resistance, we have previously reported two types of human PPARgamma gene defect: heterozygous, missense mutations (P467L, V290M) in the ligand binding domain (LBD) which inhibit wild type (WT) receptor action in a dominant negative manner by recruitment of transcriptional corepressors; or double heterozygosity for a frameshift/pr...

ea0077oc4.2 | Adrenal and Cardiovascular | SFEBES2021

Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.

Argentesi Giulia , Azizan Elena , Zhou Junhua , Cabrera Claudia , O’Toole Sam , Wu Xilin , Goodchild Emily , Cottrell Emily , Marker Alison , Senanayake Russell , Garg Sumedha , Jordan Suzanne , Berney Dan , Gluck Anna , Lines Kate , Thakker Rajesh V , Tuthill Antoinette , Joyce Caroline , Karet Frankl Fiona , Metherell Lou , Teo Ada , Gurnell Mark , Parvanta Laila , Drake William , Wozniak Eva , Mein Chaz , Kinsler Veronika , Storr Helen , Brown Morris

Most aldosterone-producing adenomas (APAs) have gain-of-function somatic mutations of ion channels or transporters. However, their frequency in aldosterone-producing cell-clusters of normal adrenals could suggest the existence of co-driver mutations which influence the development or phenotype of APAs [1]. Gain-of-function mutations in both CTNNB1 and the G-protein coupled receptor GNA11 were found by whole exome sequencing in 3/10 APAs. Further sequencing of...

ea0077oc4.3 | Adrenal and Cardiovascular | SFEBES2021

[11C]Metomidate PET/CT can aid decision-making in patients with primary aldosteronism

Senanayake Russell , Gillett Daniel , Ali Zahabia , Bashari Waiel , MacFarlane James , Koulouri Olympia , van der Meulen Merel , Powlson Andrew , Challis Benjamin , Palma August , Hu Lihua , Aloj Luigi , Mendichovszky Iosif , Cuthbertson Dan , Shore Susannah , Levy Miles , Drake William , Brown Morris , Kosmoliaptsis Vasilis , Marker Alison , Cheow Heok , Gurnell Mark

Background: Primary aldosteronism (PA) is the leading, potentially reversible, cause of secondary hypertension. For most patients in whom surgery is being considered, adrenal vein sampling (AVS) is recommended to distinguish unilateral and bilateral causes. However, AVS remains technically challenging, and a significant proportion of patients are unable to progress to surgery because AVS is unavailable or unsuccessful. We have explored whether [11C]Metomidate PET/CT...

ea0050p269 | Neuroendocrinology and Pituitary | SFEBES2017

Male IGSF1 deficient humans and mice exhibit somatotroph neurosecretory hyperfunction

Joustra Sjoerd D , Roelfsema Ferdinand , Endert Erik , van Trotsenburg ASPaul , Fliers Eric , Schneider Harald J , Kosilek Robert P , Kroon Herman M , Logan John , Turgeon Marc-Olivier , Zhou Xiang , Toufaily Chirine , Koulouri Olympia , Gurnell Mark , Bassett JHDuncan , Williams Graham R , Oostdijk Wilma , Wit Jan-Maarten , Pereira Alberto M , Biermasz Nienke R , Bernard Dan J , Schoenmakers Nadia

X-linked IGSF1 (immunoglobulin superfamily, member 1) loss-of-function mutations in males are associated with central hypothyroidism, macroorchidism, and a variable spectrum of anterior pituitary dysfunction. Igsf1 deficient male mice also exhibit central hypothyroidism, however, the physiological and molecular function of IGSF1 in both species has not yet been elucidated. Although partial transient GH deficiency is a ra...